Diagnosing and managing advanced chronic myeloid leukemia

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting

Volumn , Issue , 2015, Pages e381-e388

  Deininger, Michael W ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; BCR-ABL1 FUSION PROTEIN, HUMAN; ENZYME INHIBITOR; PROTEIN TYROSINE KINASE;

ANTAGONISTS AND INHIBITORS; DISEASE COURSE; DRUG RESISTANCE; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MUTATION; RISK ASSESSMENT; TREATMENT FAILURE;

DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; FUSION PROTEINS, BCR-ABL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MUTATION; PROTEIN-TYROSINE KINASES; RISK ASSESSMENT; TREATMENT FAILURE;

EID: 85003946096     PISSN: None     EISSN: 15488756     Source Type: Journal    
DOI: 10.14694/EdBook_AM.2015.35.e381     Document Type: Review

References (0)